(258 days)
Not Found
No
The summary describes a surgical mesh made of synthetic fibers and collagen coating, intended for soft tissue reinforcement. There is no mention of any computational analysis, image processing, or algorithms that would suggest the use of AI or ML. The performance studies focus on physical, mechanical, and biocompatibility characteristics.
No
The device is described as a reinforcing or bridging material for soft tissues and tendons, not a device that provides therapy for a disease or condition.
No
The device is a surgical scaffold used to reinforce soft tissues, not to diagnose medical conditions.
No
The device description clearly states it is a "bi-layer, synthetic absorbable reinforced woven fabric made from poly(4-hydroxybutyrate) fibers," indicating it is a physical, implantable medical device, not software.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly describes a device used in vivo (within the body) for surgical repair and reinforcement of soft tissues. IVDs are used in vitro (outside the body) to examine specimens from the human body to provide information for diagnosis, monitoring, or screening.
- Device Description: The description details a surgical scaffold made of synthetic material, designed to be implanted. This is consistent with a surgical device, not an IVD.
- Lack of IVD Characteristics: There is no mention of analyzing biological samples, reagents, calibrators, controls, or any other components typically associated with IVD devices.
- Performance Studies: The performance studies described focus on physical, mechanical, biocompatibility, and biodegradation characteristics, which are relevant to implanted surgical devices, not IVDs.
Therefore, the Tornier® Collagen Coated BioFiber Scaffold is a surgical mesh intended for implantation, not an in vitro diagnostic device.
N/A
Intended Use / Indications for Use
Tornier® Collagen Coated BioFiber Scaffold is intended for use where temporary wound support is required to reinforce soft tissues where weakness exists or for the repair of hernia or other fascial defects that require the addition of a reinforcing or bridging material to obtain the desired surgical result.
Tornier® Collagen Coated BioFiber Scaffold is also intended for reinforcement of soft tissues, in conjunction with sutures and/or suture anchors during tendon repair surgery; including the reinforcement of rotator cuff, patellar, Achilles, biceps and quadriceps tendons.
Tornier® Collagen Coated BioFiber Scaffold is not intended for use as a replacement for normal body structures or to provide the full mechanical strength to support the rotator cuff, patellar, Achilles, biceps, or quadriceps tendons. Sutures, used to repair the tear, and sutures or bone anchors, used to attach the tissue to the bone, provide mechanical strength for the tendon repair.
Product codes
FTL
Device Description
Tornier® Collagen Coated BioFiber™ Scaffold is a bi-layer, synthetic absorbable reinforced woven fabric made from poly(4-hydroxybutyrate) fibers. The construction permits the mesh to be cut into any desired shape or size without unraveling. The device is supplied sterile, for single-patient use for the reinforcement of soft tissue where weakness exists.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
soft tissues, hernia or other fascial defects, rotator cuff, patellar, Achilles, biceps and quadriceps tendons.
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Tornier has presented data regarding the physical and mechanical characteristics as outlined in the FDA "Guidance for the Preparation of a Premarket Notification for a Surgical Mesh". In addition, Tornier has conducted studies of collagen purity, biocompatibility testing in accord with ISO 10993, a functionality study, a shelf-life study and a biodegradation study.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
K070894, K102788, K093799, K073287, K071887
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 878.3300 Surgical mesh.
(a)
Identification. Surgical mesh is a metallic or polymeric screen intended to be implanted to reinforce soft tissue or bone where weakness exists. Examples of surgical mesh are metallic and polymeric mesh for hernia repair, and acetabular and cement restrictor mesh used during orthopedic surgery.(b)
Classification. Class II.
0
1 of 3
510(k) SUMMARY (Per 21 CFR 807.92)
JAN 2 5 2012
స్టే
General Company Information
| Name: | Tornier, Inc. |
|---|---|
| Contact: | Howard Schrayer |
| Regulatory Affairs Consultant |
7701 France Avenue South - Suite 600 Address: Edina, MN 55435
| Telephone: | 952-426-7641 |
|---|---|
| Fax: | 952-426-7601 |
- Date Prepared January 11, 2012
General Device Information
| Product Name: | Tornier® Collagen Coated BioFiber™ Scaffold |
|---|---|
| --------------- | --------------------------------------------- |
Classification: "Absorbable Surgical Mesh" Product code: FTL - Class II
Predicate Devices
| Tepha, Inc., Inc. | TephaFLEXTM Surgical Mesh
[510(k) Number K070894] |
|-----------------------------------|--------------------------------------------------------------------------------|
| Tornier, Inc. | Tornier® BioFiberTM Scaffold - (Surgical Mesh)
[510(k) K102788 and K093799] |
| Sofradim Production
(Covidien) | PREVADHTM Surgical Mesh
[510(k) K073287] |
| Artimplant AB | Artelon® SportMeshTM Tissue Reinforcement Mesh
[510(k) K071887] |
1
11/ 1337 20F3
Description
Tornier® Collagen Coated BioFiber™ Scaffold is a bi-layer, synthetic absorbable reinforced woven fabric made from poly(4-hydroxybutyrate) fibers. The construction permits the mesh to be cut into any desired shape or size without unraveling. The device is supplied sterile, for single-patient use for the reinforcement of soft tissue where weakness exists.
Intended Use (Indications)
Tornier® Collagen Coated BioFiber™ Scaffold is intended for use where temporary wound support is required to reinforce soft tissues where weakness exists or for the repair of hernia or other fascial defects that require the addition of a reinforcing or bridging material to obtain the desired surgical result.
Tornier® Collagen Coated BioFiber™ Scaffold is also intended for reinforcement of soft tissues, in coniunction with sutures and/or suture anchors during tendon repair surgery; including the reinforcement of rotator cuff, patellar, Achilles, biceps and quadriceps tendons.
Tornier® Collagen Coated BioFiber™ Scaffold is not intended for use as a replacement for normal body structures or to provide the full mechanical strength to support the rotator cuff, patellar, Achilles, biceps, or quadriceps tendons. Sutures, used to repair the tear, and sutures or bone anchors, used to attach the tissue to the bone, provide mechanical strength for the tendon repair.
Substantial Equivalence
The mesh structure of the Collagen Coated BioFiber™ Scaffold is the same material used to form the mesh used in the predicate TephaFLEX™ Surgical Mesh and both the material and mesh structure are the same as that of the predicate Tornier® BioFiber™ Scaffold. The use of the collagen coating as a component of the Collagen Coated BioFiber™ Scaffold is equivalent to the structure used for the predicate PREVADH™ Surgical Mesh and the predicate Artelon® SportMesh™ Tissue Reinforcement Mesh.
In support of the claim of substantial equivalence, Tornier has presented data regarding the phvsical and mechanical characteristics as outlined in the FDA "Guidance for the Preparation of a Premarket Notification for a Surgical Mesh". In addition, Tornier has conducted studies of collagen purity, biocompatibility testing in accord with ISO 10993, a functionality study, a shelf-life study and a biodegradation study.
This submission supports the position that the Tornier® Collagen Coated BioFiber™ Scaffold is substantially equivalent to previously cleared devices, including those listed above. A number of predicate devices list the same range of clinical uses.
2
ר331 ווא 30f3
Conclusions
Tornier, Inc. believes that the information provided establishes that similar legally marketed devices have been used for the same clinical applications as the Tornier® Collagen Coated BioFiber™ Scaffold. The materials from which the Tornier device is fabricated have an established history of use, and the devices have been tested in accordance with applicable FDA guidelines.
3
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/3/Picture/1 description: The image is a logo for the Department of Health & Human Services - USA. The logo features a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is an abstract symbol resembling an eagle or bird in flight, composed of curved lines. The logo is presented in black and white.
Public Health Service
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002
JAN 2 5 2012
Tornier, Inc. % Mr. Howard Schrayer 7701 France Avenue South - Suite 600 Edina, Minnesota 55435
Re: K111337
Trade/Device Name: Tornier® Collagen Coated BioFiber Scaffold Regulation Number: 21 CFR 878.3300 Regulation Name: Surgical mesh Regulatory Class: Class II Product Code: FTL Dated: January11, 2012 Received: January 12, 2012
Dear Mr. Schrayer:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you; however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must
4
Page 2 - Mr. Howard Schrayer .
comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.
Sincerely vours.
cerely yours,
Mark N. Melkerson Director Division of Surgical, Orthopedic and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
5
INDICATIONS FOR USE
510(k) Number (if known): 〈〈〈 | | | 33フ
Device Name: Tomier® Collagen Coated BioFiber Scaffold
Indications For Use:
Tornier® Collagen Coated BioFiber Scaffold is intended for use where temporary wound support is required to reinforce soft tissues where weakness exists or for the repair of hernia or other fascial defects that require the addition of a reinforcing or bridging material to obtain the desired surgical result.
Tornier® Collagen Coated BioFiber Scaffold is also intended for reinforcement of soft tissues, in conjunction with sutures and/or suture anchors during tendon repair surgery; including the reinforcement of rotator cuff, patellar, Achilles, biceps and quadriceps tendons.
Tornier® Collagen Coated BioFiber Scaffold is not intended for use as a replacement for normal body structures or to provide the full mechanical strength to support the rotator cuff, patellar, Achilles, biceps, or quadriceps tendons. Sutures, used to repair the tear, and sutures or bone anchors, used to attach the tissue to the bone, provide mechanical strength for the tendon repair.
Prescription Use (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
David Krane for MXIM
(Division Sign-Off) Division of Surgical, Orthopedic, and Restorative Devices
510(k) Number K111337